Sino BiologicalInc Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Zhang Jie

Chief executive officer

CN¥2.7m

Total compensation

CEO salary percentagen/a
CEO tenure6.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.8yrs

Recent management updates

Recent updates


CEO

Zhang Jie (51 yo)

6.9yrs

Tenure

CN¥2,740,800

Compensation

Mr. Zhang Jie, Ph D, serves as R&D Director of Sino Biological Inc. He is General Manager of Sino Biological Inc since 2018 and is its MD & Director. Mr. Zhang graduated from Beijing Medical Sciences Unive...


Board Members

NamePositionTenureCompensationOwnership
Zhang Jie
GM, MD, R&D Director & Director4.8yrsCN¥2.74mno data
Tao Feng
CFO, Secretary to the Board & Non-Independent Director4.8yrsCN¥1.20mno data
Liangzhi Xie
Founder4.8yrsno data55.81%
CN¥ 4.3b
Daniel I. Wang
Chairman of Scientific Advisory Boardno datano datano data
Yanmin Tang
Non-Independent Director4.8yrsno datano data
Baiyang Sheng
Non-Independent Director1.8yrsno datano data
Xiaofang Chen
Non-Independent Director4.8yrsno datano data
Shizhou Yin
Independent Director4.8yrsCN¥120.00kno data
Changyuan Yu
Independent Director4.8yrsCN¥120.00kno data
Yong You
Independent Director1.8yrsCN¥90.00kno data
Jing Wang
Chairman of the Supervisory Board4.8yrsno datano data
Xiaotong Wang
Supervisor1.3yrsno datano data

4.8yrs

Average Tenure

51yo

Average Age

Experienced Board: 301047's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:57
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sino Biological,Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jiaying FuChina International Capital Corporation Limited
Zhu ChenCitic Securities Co., Ltd.
Kai WangCitic Securities Co., Ltd.